| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.41B | +5.6% |
| R&D Expense | $310.5M | -3.2% |
| SG&A Expense | $185.0M | -12.9% |
| Operating Income | $151.0M | +91.1% |
| Pre-tax Income | $183.0M | +74.1% |
| Income Tax | $50.1M | +748.0% |
| Net Income | $132.8M | +34.0% |
| EPS (Basic) | $1.97 | +37.8% |
| EPS (Diluted) | $1.88 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $217.3M | -30.8% |
| Short-term Investments | $100.6M | -21.1% |
| Accounts Receivable | $155.3M | +6.3% |
| Current Assets | $516.9M | -17.2% |
| Total Assets | $983.6M | -3.1% |
| Current Liabilities | $155.0M | -11.9% |
| Total Liabilities | $239.6M | -9.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $285.8M | -6.7% |
| Capital Expenditures | $37.3M | +39.1% |
| Investing Cash Flow | -$77.3M | -41.3% |
| Financing Cash Flow | -$303.8M | -23.1% |
| Free Cash Flow | $248.5M | -11.1% |
| +39.3% |
| Stockholders' Equity |
| $744.0M |
| -0.7% |